GENEVA, Oct. 28 -- PROLONG PHARMACEUTICALS LLC (300 CORPORATE COURT, SUITE BSOUTH PLAINFIELD, New Jersey 07080) filed a patent application (PCT/US2025/025254) for "METHOD OF TREATING CANCER USING PEGYLATED BOVINE HEMOGLOBIN" on Apr 17, 2025. With publication no. WO/2025/222059, the details related to the patent application was published on Oct 23, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): JUBIN, Ronald (25 BIRCHWOOD LANEWATCHUNG, New Jersey 07069)
Abstract: The present invention provides a method of treating cancer by administering PEGylated HB-CO (PEG-HB-CO) in combination with radia...